ClinicalTrials.Veeva

Menu
B

Baguio General Hospital and Medical Center | Internal Medicine

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MLC1501
Domvanalimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body (STAR-221)

This randomized Phase 3 open-label study will compare the efficacy of the T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (I...

Active, not recruiting
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Drug: Domvanalimab
Drug: Zimberelimab

This is a multi-center, randomized, double-blind, placebo-controlled trial of MLC1501 in patients with stroke. Eligible participants will be randomiz...

Enrolling
Stroke, Cardiovascular
Stroke
Drug: MLC1501
Other: Placebo

Trial sponsors

Arcus Biosciences logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems